Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
An experimental drug designed to block the advance of type 1 diabetes in its earliest stages has proven strikingly effective over two years in about half of the patients who participated in the phase 2 clinical trial.
Patients who benefited most were those who still had relatively good control of their blood sugar levels and only a moderate need for insulin injections when the trial began. With the experimental drug, teplizumab, they were able to maintain their level of insulin production for the full two years -- longer than with most otherdrugs tested against the disease.
http://www.sciencedaily.com/releases/2013/08/130807155152.htm
Wonder if it would help me?
Patients who benefited most were those who still had relatively good control of their blood sugar levels and only a moderate need for insulin injections when the trial began. With the experimental drug, teplizumab, they were able to maintain their level of insulin production for the full two years -- longer than with most otherdrugs tested against the disease.
http://www.sciencedaily.com/releases/2013/08/130807155152.htm
Wonder if it would help me?